Determination of nicotine and cotinine in human serum by means of LC/MS.
As part of a joint clinical research project to study the effects of nicotine on the brain, a HPLC electrospray ionisation mass spectrometry method with a solid-phase extraction sample preparation was developed for the quantitative determination of nicotine and cotinine in human serum in volunteers. The measured concentrations of nicotine and cotinine were used as control for smoking behaviour. A X-Bridge-column from Waters, and a SSQ 7000 single quadropole mass spectrometer with a TSP liquid chromatographic system were used. The method includes a simple and robust sample preparation and this assay has been shown to be of a sufficient sensitivity for this application. The limits of quantification were 5 and 2ng/ml for cotinine and nicotine, respectively. A simultaneous study was conducted to measure nicotine receptor availability and the vigilance in the same group of volunteers.
Baumann
F
F
Institute of Clinical Pharmacology, University of Leipzig, Leipzig, Germany. baumf@medizin.uni-leipzig.de
Regenthal
R
R
Burgos-Guerrero
I L
IL
Hegerl
U
U
Preiss
R
R
D002853:Chromatography, Liquid / Q000379:methods*; D003367:Cotinine / Q000097:blood*; D004355:Drug Stability; D006801:Humans; D016014:Linear Models; D013058:Mass Spectrometry / Q000379:methods*; D009538:Nicotine / Q000097:blood*; D012680:Sensitivity and Specificity; D052616:Solid Phase Extraction; D013048:Specimen Handling
D009538:Nicotine; D003367:Cotinine